{"nct_id":"NCT01484496","title":"A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)","status":"COMPLETED","status_verified_date":"2018-05","start_date":"2011-11-16","start_date_type":null,"primary_completion_date":"2015-02-13","primary_completion_date_type":"ACTUAL","completion_date":"2015-10-01","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}